Log In
Print
BCIQ
Print
Print this Print this
 

Pulmicort Respules, budesonide

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionNebulized anti-inflammatory corticosteroid
Molecular Target Corticoid receptors
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAsthma
Indication DetailsTreat asthma; Treat children with asthma; Treat chronic obstructive pulmonary disease (COPD); Treat severe, oral corticosteroid-dependent asthma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today